Decompensated Cirrhosis: New Human Albumin Solution

We are studying a new human albumin solution to see if it is safer and more effective than the standard treatment for patients with decompensated cirrhosis. This research aims to improve clinical outcomes for those needing long-term albumin therapy.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Albunorm

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Glutathione
Glutathione is a naturally occurring antioxidant that helps protect cells from damage and supports liver detoxification.
Glutathione (Reduced)
Glutathione (Reduced) is a natural antioxidant that helps protect cells from oxidative damage and supports liver detoxification.
Human Albumin Solution
Human albumin solution is a blood-derived protein that restores blood volume and maintains fluid balance in those with low blood protein or severe fluid loss.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Albuman
Albumin Octapharma
Crealb

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Semeiotica medica
Bologna, Italy
Azienda Ospedaliera di Padova
Dip. Medicina dei Sistemi, UOC Gastroenterologia
Padova, Italy
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
PROMISE, UOC Gastroenterologia
Palermo, Italy

Sponsor: Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.